Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial

Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial

(2018) Wen Wan et al.   DIABETES CARE

Valuing health-related quality of life: An EQ-5D-5L value set for England

(2017) Nancy J. Devlin et al.   HEALTH ECONOMICS

A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial

(2017) Simon Heller et al.   HEALTH TECHNOLOGY ASSESSMENT

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections

(2017) Roy W. Beck et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial

(2017) Roy W Beck et al.   Lancet Diabetes & Endocrinology

Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study

(2016) Jan Šoupal et al.   Diabetes Technology & Therapeutics

Erratum to: Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2016)   DIABETOLOGIA

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

(2016) Gillian D. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus

(2016) Martin Henriksson et al.   PHARMACOECONOMICS

Beneficios clínicos y económicos de la terapia con bomba de insulina integrada a sistema de monitoreo continuo de glucosa en los pacientes diabéticos tipo 1 en Colombia

(2016) Ana Maria Gomez et al.   Endocrinologia y Nutricion

Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

(2015) Kellee M. Miller et al.   DIABETES CARE

Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources

(2015) S. R. Heller et al.   DIABETIC MEDICINE

Development and validation of a cost-utility model for Type 1 diabetes mellitus

(2015) S. Wolowacz et al.   DIABETIC MEDICINE

Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes

(2015) S. Roze et al.   DIABETIC MEDICINE

Trends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010

(2014) Elizabeth Selvin et al.   ANNALS OF INTERNAL MEDICINE

The Effect of Hypoglycemia on Health-Related Quality of Life: Canadian Results from a Multinational Time Trade-off Survey

(2014) Stewart Harris et al.   Canadian Journal of Diabetes

7. Approaches to Glycemic Treatment

(2014)   DIABETES CARE

Medicaid Increases Emergency-Department Use: Evidence from Oregon's Health Insurance Experiment

(2014) S. L. Taubman et al.   SCIENCE

The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys

(2014) Gregory Fulcher et al.   JOURNAL OF MEDICAL ECONOMICS

Comparing Costs and Quality of Care at Retail Clinics With That of Other Medical Settings for 3 Common Illnesses

(2013) Ateev Mehrotra et al.   ANNALS OF INTERNAL MEDICINE

Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus

(2013) Hsin-Chieh Yeh et al.   ANNALS OF INTERNAL MEDICINE

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

(2013) David M. Nathan et al.   DIABETES CARE

Assessing the cost-effectiveness of Type 1 diabetes interventions: the Sheffield Type 1 Diabetes Policy Model

(2013) P. Thokala et al.   DIABETIC MEDICINE

Simulating Lifetime Outcomes Associated with Complications for People with Type 1 Diabetes

(2013) Tom W. C. Lung et al.   PHARMACOECONOMICS

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

(2013) Don Husereau et al.   VALUE IN HEALTH

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

(2012) T. Battelino et al.   DIABETOLOGIA

A health economic analysis of clinical islet transplantation

(2011) Jessica Beckwith et al.   CLINICAL TRANSPLANTATION

The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes

(2010) E. S. Huang et al.   DIABETES CARE

Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada

(2009) Meaghan E.St. Charles et al.   CLINICAL THERAPEUTICS

Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain

(2009) E. Marrett et al.   DIABETES OBESITY & METABOLISM

Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France

(2008) P. Vexiau et al.   DIABETES OBESITY & METABOLISM

A Cost-Effectiveness Analysis of Continuous Subcutaneous Insulin Injection versus Multiple Daily Injections in Type 1 Diabetes Patients: A Third-Party US Payer Perspective

(2008) Meaghan St Charles et al.   VALUE IN HEALTH